» Articles » PMID: 24255130

The Relationship Between Markers of Extracellular Cardiac Matrix Turnover: Infarct Healing and Left Ventricular Remodelling Following Primary PCI in Patients with First-time STEMI

Overview
Journal Eur Heart J
Date 2013 Nov 21
PMID 24255130
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We investigated the temporal changes in circulating levels of markers of extracellular cardiac matrix (ECCM) turnover and their relationship with infarct size (IS), ejection fraction (EF), and left ventricular (LV) volumes, determined by serial cardiac magnetic resonance (CMR) imaging in patients with first-time ST-elevation myocardial infarction (STEMI).

Methods And Results: Forty-two patients with a first-time STEMI, successfully revascularized by primary percutaneous coronary intervention (pPCI) had serum samples taken prior to pPCI, 2, 7 days, 2 months, and 1 year following STEMI for the analysis of the markers of collagen synthesis, and collagen degradation. Late enhancement and cine CMR was performed on Days 2, 7, 2 months, and 1-year post-STEMI. There was a significant increase in type I collagen degradation following STEMI that was not accompanied by an increase in collagen type I synthesis until 2 months and 1 year. In contrast to the delay in type I collagen synthesis, there was an immediate increase in type III collagen synthesis that was sustained for 1 year. N-terminal procollagen type I levels assessed prior to pPCI were predictive of adverse LV remodelling at all CMR time-points.

Conclusions: Our findings indicate a net type I collagen breakdown in the first week following STEMI compensated by an early increase in collagen type III synthesis. There is an increase in both type I and III collagen synthesis markers at 2 months and 1 year, indicating a persistent increase in collagen turnover even in these apparently successfully treated patients.

Citing Articles

WISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts' Activation and Collagen Processing.

Li Z, Williams H, Jackson M, Johnson J, George S Cells. 2024; 13(11.

PMID: 38891121 PMC: 11172092. DOI: 10.3390/cells13110989.


Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin.

Andersen T, Ueland T, Aukrust P, Nilsen D, Grundt H, Staines H Front Cardiovasc Med. 2023; 10:1191055.

PMID: 37731526 PMC: 10507464. DOI: 10.3389/fcvm.2023.1191055.


Cluster analysis of extracellular matrix biomarkers predicts the development of impaired systolic function within 1 year of acute myocardial infarction.

Brunton-OSullivan M, Holley A, Shi B, Harding S, Larsen P Heart Vessels. 2022; 37(12):2029-2038.

PMID: 35896723 PMC: 9579085. DOI: 10.1007/s00380-022-02118-8.


Preventive Effect Observation of Dapagliflozin on Middle and Later Ventricular Remodeling in Patients with Acute ST Segment Elevation Anterior Wall Myocardial Infarction: A Single-Center, Retrospective Cohort Study.

Liu Z, Liu L, Zhang H, Jiang Y, Wang H J Healthc Eng. 2022; 2022:3955914.

PMID: 35463678 PMC: 9033370. DOI: 10.1155/2022/3955914.


Extracellular Matrix Protein Ratios in the Human Heart and Vessels: How to Distinguish Pathological From Physiological Changes?.

Wittig C, Szulcek R Front Physiol. 2021; 12:708656.

PMID: 34421650 PMC: 8371527. DOI: 10.3389/fphys.2021.708656.